Recent findings have shown that nuclear PD-L1, which is acetylated at K263 by p300 and deacetylated by HDAC2, acts as a transcription factor that alters gene expression related to antigen presentation and inflammatory pathways, affecting cytotoxic T lymphocyte activity and tumor immune evasion [126]. The gene discussed is HDAC2; the disease is neoplasm.